Victory Capital Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.03M | Sell |
90,932
-11,479
| -11% | -$634K | ﹤0.01% | 1322 |
|
|
2025
Q1 | $4.95M | Sell |
102,411
-138,406
| -57% | -$6.69M | 0.01% | 1283 |
|
|
2024
Q4 | $9.3M | Buy |
240,817
+110,020
| +84% | +$4.25M | 0.01% | 1108 |
|
|
2024
Q3 | $5.89M | Buy |
130,797
+123,647
| +1,729% | +$5.56M | 0.01% | 1235 |
|
|
2024
Q2 | $248K | Sell |
7,150
-58
| -0.8% | -$2.01K | ﹤0.01% | 2149 |
|
|
2024
Q1 | $209K | Buy |
+7,208
| New | +$209K | ﹤0.01% | 2213 |
|
|
2022
Q1 | – | Sell |
-9,612
| Closed | -$329K | – | 2795 |
|
|
2021
Q4 | $329K | Buy |
+9,612
| New | +$329K | ﹤0.01% | 2351 |
|
|
2021
Q3 | – | Sell |
-845,199
| Closed | -$37.9M | – | 2835 |
|
|
2021
Q2 | $37.9M | Buy |
+845,199
| New | +$37.9M | 0.04% | 667 |
|
|
2020
Q2 | – | Sell |
-6,652
| Closed | -$46K | – | 3088 |
|
|
2020
Q1 | $46K | Buy |
+6,652
| New | +$46K | ﹤0.01% | 2809 |
|
|
2019
Q4 | – | Sell |
-3,250
| Closed | -$39K | – | 3109 |
|
|
2019
Q3 | $39K | Buy |
+3,250
| New | +$39K | ﹤0.01% | 2795 |
|